CDC
-
CDC Investigating Harmful Reactions to Counterfeit Botox
A CDC investigation notice has been posted regarding harmful reactions in people who received counterfeit or otherwise mishandled botox: www.cdc.gov/botulism/outbreaks/harmful-reactions-botox-injections.html Read the original news at Centers for Disease Control and…
-
CDC Data Modernization Efforts Accelerate Nation’s Ability to Detect and Rapidly Respond to Health Threats
Today the Centers for Disease Control and Prevention (CDC) launched its updated Public Health Data Strategy for 2024-2025 and a companion 2023 Lookback Report. Read the original news at Centers…
-
Transcript for Vital Signs: Health-Related Social Needs Can Keep Women from Getting Lifesaving Mammograms
Transcript for Vital Signs: Health-Related Social Needs Can Keep Women from Getting Lifesaving Mammograms Read the original news at Centers for Disease Control and Prevention (CDC)
-
Cost and Access Are Not the Only Barriers Women Face in Getting Lifesaving Mammograms
A new CDC Vital Signs study finds that only about 65% of women ages 50-74, with three or more health-related social needs, are up to date with their mammograms.Breast cancer…
-
Highly Pathogenic Avian Influenza A (H5N1) Virus Infection Reported in a Person in the U.S.
April 1, 2024-A person in the United States has tested positive for highly pathogenic avian influenza (HPAI) A(H5N1) virus (“H5N1 bird flu”), as reported by Texas and confirmed by CDC.…
-
CDC’s National Institute for Occupational Safety and Health’s Impact Wellbeing(TM) Campaign Releases Hospital-Tested Guide to Improve Healthcare Worker Burnout
As part of the first federal campaign to address healthcare worker burnout, the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) today released…
-
CDC Statement on the President’s Fiscal Year 2025
Today, the Biden-Harris Administration released the President’s Budget for Fiscal Year (FY) 2025. The Centers for Disease Control and Prevention (CDC) budget request for FY 2025 includes $9.683 billion in…
-
CDC study shows effectiveness of RSV immunization for infants
New data released today in CDC’s MMWR show that nirsevimab, a long-acting monoclonal antibody product, was highly effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV). Read…
-
CDC updates and simplifies respiratory virus recommendations
CDC released today updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. Read the original news at Centers for Disease Control and Prevention…
-
Older Adults Now Able to Receive Additional Dose of Updated COVID-19 Vaccine
Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for adults ages 65 years and older to receive an additional updated 2023-2024 COVID-19 vaccine…